-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HDP-101 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HDP-101 in Relapsed Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HDP-101 in Relapsed Multiple Myeloma Drug Details: HDP-101 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HDP-101 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HDP-101 in Refractory Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HDP-101 in Refractory Multiple Myeloma Drug Details: HDP-101 is under...
-
Product Insights
NewOptical Coherence Tomography (OCT) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Optical Coherence Tomography Pipeline Market Report Overview Optical coherence tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. The optical coherence tomography pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories · United...
-
Product Insights
NewHummingbird Diagnostics GmbH Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Hummingbird Diagnostics GmbH Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Hummingbird Diagnostics GmbH (Hummingbird), is a provider of clinical research and testing services. It develops miRNA-based liquid biopsy diagnostics that find application in early detection of disease indications. The company discovers, validates and analyzes genomic biomarkers especially derived from body fluid samples. It offers multilevel biomarker services and solutions. Hummingbird’s services comprise DNA and RNA extraction services, validation of...
-
Product Insights
NewMRC Systems GmbH Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MRC Systems GmbH Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MRC Systems GmbH (MRC Systems) is a medical device company that offers medical, electronic and laser optical products. The company’s products include laser beam stabilization, MR compatible cameras, pinprick, cardioman, photoactivation and stereotactic systems. It offers laser beam stabilization systems for the real-time stabilization, alignment, positioning and adjustment of laser beams. MRC Systems’s cardionan systems are used to identify...
-
Product Insights
NewComputed Tomography (CT) Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Computed Tomography (CT) Systems Pipeline Market Report Overview Computed Tomography (CT) is a powerful and non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. It is used on patients with a high risk of colon cancer or full-motion heart scans for patients with a high risk of heart disease. The CT systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at...
-
Company Insights
Innovation and Patenting activity of Heidelberger Druckmaschinen AG Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Heidelberger Druckmaschinen AG Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Analyst Opinions
Net Zero by 2050 – Industrial Decarbonization Gains Momentum (Vol.2)
Net Zero by 2050 Overview Businesses and tech giants globally are focusing on low-carbon products, renewables, and EVs to achieve net zero emissions. Key sectors such as aerospace, automotive, and technology are advancing sustainability through innovations in hydrogen, EVs, fuel cells, and smart energy solutions among others. The “Net Zero by 2050” report outlines decarbonization-related deals value and volume trends, VC investment activity and geographic trends, and leading investors. The report also provides facts and figures related to climate change,...
-
Product Insights
NewHerpes Labialis (Oral Herpes) – Drugs In Development, 2024
Empower your strategies with our Herpes Labialis (Oral Herpes) – Drugs In Development, 2024 report and make more profitable business decisions. Oral herpes is an infection of the lips, mouth, or gums by the herpes simplex virus. Oral herpes is also called herpes labialis. Symptoms include sore throat, fever, swollen glands, and painful swallowing. Treatment includes antiviral medications. The Herpes Labialis (Oral Herpes) drugs in development market research report provide comprehensive information on the therapeutics under development for Herpes Labialis (Oral...
-
Product Insights
NewGenital Herpes – Drugs In Development, 2024
Empower your strategies with our Genital Herpes – Drugs In Development, 2024 report and make more profitable business decisions. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite; fever; general sick feeling (malaise); muscle aches in the lower back, buttocks, thighs, or knees; and swollen and tender lymph nodes in the groin during an outbreak. Treatment includes antiviral medications. The Genital Herpes...